U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Safety
  3. Recalls, Market Withdrawals, & Safety Alerts
  4. Megadyne Reiterates Intended Use Population Change for Megadyne Mega Soft Universal and Universal Plus Patient Return Electrodes
  1. Recalls, Market Withdrawals, & Safety Alerts

COMPANY ANNOUNCEMENT

Megadyne Reiterates Intended Use Population Change for Megadyne Mega Soft Universal and Universal Plus Patient Return Electrodes

When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company.

Read Announcement View Product Photos

Summary

Company Announcement Date:
FDA Publish Date:
Product Type:
Medical Devices
Reason for Announcement:
Recall Reason Description
Limit use to patients aged 12 years or older.
Company Name:
Megadyne Medical Products, Inc.
Brand Name:
Brand Name(s)
Megadyne
Product Description:
Product Description
Mega Soft Universal and Universal Plus Reusable Patient Return Electrodes

Company Announcement

Cincinnati, OH – February 29, 2024 – On December 8, 2023, Megadyne issued a Class 1 Medical Device Correction to hospitals to limit the use of MEGA SOFT Universal and Universal Plus Reusable Patient Return Electrodes to patients aged 12 years or older after receiving reports of adult and pediatric patient burns following surgical procedures in which MEGA SOFT pads were used. These reports of patient burn injuries described up to and including third-degree burns requiring intervention which may lead to prolonged hospital stay, scarring, and additional surgeries in both pediatric and adult patients. Severe burns could lead to potentially long-lasting impacts on patients especially under the age of 12 years.

Since that notification, we have continued to monitor device performance through post market surveillance, investigated every event reported and evaluated potential root cause of these events. Megadyne recently received a report of pediatric use that included a serious 3rd degree patient burn. We are providing this additional broad public communication to increase awareness that MEGADYNE™ MEGA SOFT™ Universal and Universal Plus products should not be used for patients under the age of 12 years.

The table below contains the specific product and codes in scope. The following product codes should not be used for patients that are neonatal, infant, and children under the age of 12 years old:

Product Name Product
Code		 UDI-DI
MEGADYNE™ MEGA SOFT™ Universal Patient Return Electrode 0845 10614559103906
MEGADYNE™ MEGA SOFT™ Universal Dual Patient Return Electrode 0846 10614559104248
MEGADYNE™ MEGA SOFT™ Universal Plus Patient Return Electrode 0847 10614559104842
MEGADYNE™ MEGA SOFT™ Universal Plus Dual Patient Return Electrode 0848 10614559104859

What to do
Customers should review and follow the instructions provided in the December 2023 recall notification. Mega Soft Universal and Universal Plus Reusable Patient Return Electrodes pads may continue to be used for patients over 12 years of age.

A link to the customer notification can be found here.

Confirm that personnel using the Mega Soft Universal and Universal Plus pads understand the intended use is changing to patients aged 12 years and older and have stopped using the pads on patients under the age of 12 years. Hospitals using this product should confirm receipt of the recall notification using the business reply form provided with the initial recall notification.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

If you need additional copies of the recall notification or need a business reply form, please contact Sedgwick at 888-843-0254 and reference Event # 5627.

The safe and effective use of our products is top priority. If you have additional questions regarding this communication or to report any product complaints, please contact the Ethicon Resource Department at 1-877-ETHICON (1-877-384-4266). The Ethicon Resource Department is open Monday through Friday, 8:00 AM to 5:00 PM ET.

If medical engagement is requested, please have the Healthcare Provider submit the request using the Medical Information Request website: https://www.jnjmedtech.com/mir

 

Company Contact Information

Consumers:
Ethicon Resource Department
1-877-ETHICON (1-877-384-4266)

Product Photos

  • “ Label for Megadyne Universal Dual Patient Return Electrode Pad
Back to Top